Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction

Human Reproduction

Volumn 14, Issue 6, 1999, Pages 1461-1466

  Eldar Geva, T ^a,b   Wood, C ^a   Lolatgis, N ^a   Rombauts, L ^a   Kovacs, G ^a   Fuscaldo, J ^a   Trounson, A O ^a  

^a MONASH IVF   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antiphospholipid antibodies; Assisted reproductive treatment; Cumulative live birth rate; Cumulative pregnancy rate; Implantation failure

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INOSITOL PHOSPHATE; PHOSPHATIDIC ACID; PHOSPHOETHANOLAMINE; PHOSPHOLIPID ANTIBODY; PHOSPHOSERINE;

ADULT; ARTICLE; BIRTH RATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY RATE;

EID: 0033060628     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.6.1461     Document Type: Article

References (31)

1. Asherson, R.A., Khamashta, M.A., Ordi Ross, J. et al. (1989) The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine Baltimore, 68, 366-374.
2. Balasch, J., Creus, M., Fabregues, F. et al. (1998) Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Hum. Reprod., 13, 1180-1183.
3. Birdsall, M.A., Lockwood G.M., Ledger, W.L., Johnson, P.M. and Chamley L.W. (1996) Antiphospholipid antibodies in women having in-vitro fertilization. Hum. Reprod., 11, 1185-1189.
4. Birkenfeld, A., Mukaida, T., Minichiello, L., Jackson, M., Kase, N.G. and Yemini, M. (1994) Incidence of autoimmune antibodies in failed embryo transfer cycles. Am. J. Reprod. Immunol., 31, 65-68.
5. Branch, D.W., Silver, R.M., Blackwell, J.L., Reading, J.C. and Scott, J.R. (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol., 4, 614-620.
6. Cowchock, S., Smith, J.B. and Gocial, S. (1986) Antibodies to phospholipids and nuclear antigens in patients with related abortions. Am. J. Obstet. Gynecol., 155, 1002-1010.
7. Cowchock, S., Reece, E.A., Balaban, D., Branch, D.W. and Plouffe, L. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am. J. Obstet. Gynecol., 166, 1318-1323.
8. Denis, A.L., Guido, M., Adler, R.D., Bergh, P.A., Brenner, C. and Scott, R.T. (1997) Antiphospholipid antibodies and pregnancy rates and outcome in m vitro fertilization patients. Fertil. Steril., 67, 1084-1090.
9. Dmowski, W.P., Rana, N, Michalowska, J., Friberg, J., Papierniak, C. and El-Roeiy A. (1995) The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil. Steril., 63, 555-562.
10. El-Roeiy, A. Gleicher N., Friberg, J. et al. (1987) Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstet. Gynecol., 70, 163-170.
11. Fisch, B., Rikover, Y., Shohat, L. et al. (1991) The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertil. Steril., 56, 718-724.
12. Geva, E., Amit, A., Lerner-Geva, L., Azem, F., Yovel, Y. and Lessing, J.B. (1995) Autoimmune disorders: another possible cause for m vitro fertilization and embryo transfer failure. Hum. Reprod., 10, 101-104.
13. Gleicher, N., El-Roeiy, A., Confino, E. and Friberg, J. (1989) Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am. J. Obstet. Gynecol., 160, 1376-1385.
14. Gleicher, N., Liu, H.C., Dudkiewicz, A. et al. (1994) Autoantibody profiles and immunoglobulin concentrations as predictors of in vitro fertilization success. Am. J. Obstet. Gynecol., 170, 1145-1149.
15. Guzick, D.S. and Bross, D. (1992) Convenient numerical procedures for estimating cumulative pregnancy curves. Fertil. Steril., 57, 85-91.
16. Hull, M.G.R. (1992) Infertility treatment: relative effectiveness of conventional and assisted conception methods. Hum. Reprod., 7, 785-796.
17. Kaider, B., Price, D.E., Rousev, R.G. and Coulan, C.B. (1996) Antiphospholipid antibody prevalence in patients with IVF failure. Am. J. Reprod. Immunol., 35, 388-393.
18. Kowalik, A., Vichnin, M., Liu, H-C., Branch, W. and Berkeley, A. (1997) Mid-follicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome. Fertil. Steril., 68, 298-304.
19. Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin. Am. J. Obstet. Gynecol., 174, 1584-1589.
20. Kutteh, W.H., Yetman, D.L., Chantilis, S.J. and Crain, J. (1997) Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Hum. Reprod., 12, 1171-1175.
21. Lockwood, C.J., Reece, E.A., Romero, R. and Hobbins, J.C. (1986) Antiphospholipid antibody and pregnancy wastage. Lancet, ii, 742-743.
22. MacLachlan, V., Besanko, M., O'Shea, F. et al. (1989) A controlled study of luteinizing hormone releasing hormone agonist (buserelin) for the induction of folliculoaenesis before in vitro fertilization. N. Engl. J. Med., 320, 1233-1237.
23. Matzner, W., Chong, P., Xu, G. and Ching, W. (1994) Characterisation of antiphospholipid antibodies in women with recurrent spontaneous abortions. J. Reprod. Med., 39, 27-30.
24. Nip, M.M.C., Taylor, P.V., Rutherford, A.J. and Hanock, K.W. (1995) Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients; relation to reproductive outcome after in-vitro fertilization. Hum. Reprod., 10, 2564-2569.
25. Nye, E.J., Hockings, G.I., Grice, J.E. et al. (1997) Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans. J. Clin. Endocrinol. Metab., 82, 812-817.
26. Rai, R.S., Regan, L., Clifford, K. et al. (1995) Antiphospholipid antibodies and β-2 glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum. Reprod., 10, 2001-2005.
27. Rai, R. and Regen, L. (1997) Antiphospholipid antibodies, infertility and recurrent miscarriage. Curn Opin. Obstet. Gynecol., 9, 279-282.
28. Rubinstein, M., Marazzi, A. and Polak de Fried, E. (1997) Does low dose aspirin treatment improve implantation and pregnancy rates in IVF patients? (abstract). 10th World Congress on IVF and Assisted Reproduction, Vancouver, Canada.
29. Schenk, L.M., Butler, L., Morris et al. (1996) Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibodies seropositivity compared to untreated seronegative patients (abstract). Proceedings of the Annual Meeting of the American Society of Reproductive Medicine, Boston, USA.
30. Sher, G. (1997) A rational basis for selective immunotherapy in IVF patients testing seropositive to autoantibodies (abstract). 10th World Congress on IVF and Assisted Reproduction, Vancouver, Canada.
31. Sher, G., Feinman, M., Zouves, C. et al. (1994) High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod., 9, 2278-2283.